Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study
罗扎诺利西珠单抗治疗肌肉特异性酪氨酸激酶自身抗体阳性全身型重症肌无力患者的疗效和安全性:一项随机、双盲、安慰剂对照、适应性 III 期 MycarinG 研究的亚组分析
期刊:Therapeutic Advances in Neurological Disorders
影响因子:4.1
doi:10.1177/17562864241273036
Habib, Ali A; Sacconi, Sabrina; Antonini, Giovanni; Cortés-Vicente, Elena; Grosskreutz, Julian; Mahuwala, Zabeen K; Mantegazza, Renato; Pascuzzi, Robert M; Utsugisawa, Kimiaki; Vissing, John; Vu, Tuan; Wiendl, Heinz; Boehnlein, Marion; Greve, Bernhard; Woltering, Franz; Bril, Vera